Bayer
Business & Industry
- Pfizer files lawsuit against Metsera and its directors and Novo Nordisk for breach of merger agreement
- Pfizer receives early clearance from U.S. Federal Trade Commission for Metsera acquisition
- Pfizer addresses proposal for Metsera
- Bayer's Lynkuet™ (elinzanetant) approved in the U.S. for treatment of moderate to severe vasomotor symptoms due to menopause
- Novartis receives FDA approval for Rhapsido® (remibrutinib), the only oral, targeted BTKi treatment for chronic spontaneous urticaria (CSU)
Research & Development
- From inhibition to destruction - kinase drugs found to trigger protein degradation
- Experimental mRNA therapy shows potential to combat antibiotic-resistant infections
- Old drug, new use: How a cheap, century-old drug can improve life with type 1 diabetes
- Rejuvenating the blood: A new pharmacological strategy targeting RhoA in haematopoietic stem cells
- Inspired by a family's struggle, a scientist helps uncover defense against Alzheimer's disease
- How the cheese-noodle principle could help counter Alzheimer's
- New 'sensor' lets researchers watch DNA repair in real time
Conferences & Events
- Cohort data from Denmark show real-world evidence of stable protection against HPV-related cervical cancer
- New insights into T and B cells offer hope for autoimmune disease sufferers
- SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
- SAE Media Group's 6th annual 3D Cell Culture Conference
- CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
- 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
- CPHI Excellence in Pharma Award Winners 2022
Regulatory Affairs
- FDA expands artificial intelligence capabilities with agentic AI deployment
- FDA approves first gene therapy for treatment of aromatic L-amino acid decarboxylase deficiency
- FDA approves new treatment for hemophilia A or B
- FDA approves nasal spray influenza vaccine for self- or caregiver-administration
- FDA approves first nasal spray for treatment of anaphylaxis